“The doctor asked me to get the medicine prescribed here and not what you have given,” said a customer at a medical store adjacent to Hyderabad’s Nizam’s Institute of Medical Sciences (NIMS) on Wednesday. At the heart of the conversation was the issue of generic drugs and branded drugs. The mix-up involved Itragee-100 Itraconazole capsules instead of the prescribed Candiforce-200 tablet, both of which share the same chemical composition for treating fungal infections but belong to different brands.
While such occurrences are not uncommon for those who frequent medical shops, a potential change is on the horizon. Medical professionals express varying opinions with the new guidelines released by the National Medical Commission (NMC) on August 3 emphasising that all Registered Medical Practitioners (RMPs) must prescribe medications using generic names in a legible and clear manner. Some doctors believe the power balance will shift from physicians to pharmacists.
The guidelines further underscore the importance of rational drug prescription, discouraging the unnecessary use of medications and irrational combinations of fixed-dose tablets. To ensure transparency and accuracy, prescriptions provided by RMPs and medications dispensed by pharmacies should explicitly state the drug’s generic name, according to the NMC directive. The rationale behind these directives, according to the NMC, is to reduce healthcare costs for the population by advocating the use of generic drugs, which are often 30 to 80% cheaper than branded counterparts.
